{"id":"W2592568061","doi":"10.1080/14740338.2017.1300251","title":"The safety of vedolizumab for the treatment of ulcerative colitis","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Adverse effect; Internal medicine; Placebo; Population; Natalizumab; Oncology; Gastroenterology; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003384275,0.0004051611,0.0007926437,0.00002805008,0.0005345905,0.00002207491,0.0006434713,0.0002250641,0.00001557715],"category_scores_gemma":[0.0001636974,0.0002120618,0.0009916394,0.00003023544,0.0003383342,0.000002998174,0.0000806004,0.00007534764,0.000005932115],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001183537,"about_ca_system_score_gemma":0.000568975,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001943953,"about_ca_topic_score_gemma":0.00004364246,"domain_scores_codex":[0.9980959,0.0003357849,0.0007183983,0.0003980378,0.0001909909,0.0002609263],"domain_scores_gemma":[0.9970694,0.000400895,0.0008084944,0.001484223,0.0001655575,0.00007149805],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00191415,0.0001471234,7.614418e-7,0.0005745373,0.0006098005,0.000001582325,0.0002526716,0.000005824349,0.000002259282,0.001768669,0.006336257,0.9883864],"study_design_scores_gemma":[0.0009145066,0.0003184545,0.0001559044,0.001040511,0.00005751727,0.000003111065,0.00007956346,0.000007210487,0.0001518421,0.00001245201,0.9970466,0.0002123446],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00000421098,0.9937085,0.00007919148,0.0001963253,0.001112919,0.002472082,0.001242475,0.000006121049,0.001178197],"genre_scores_gemma":[0.00008941327,0.9964274,0.00003876982,0.0000265817,0.0007758046,0.0007266555,0.00064555,0.00005215891,0.001217629],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9907103,"threshold_uncertainty_score":0.8647631,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04964723140641666,"score_gpt":0.372528495254814,"score_spread":0.3228812638483973,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}